Report overview
Immuno-Cell Therapy is known as a systemic treatment with minimal adverse reaction in cancer treatment. Basic concept of the therapy is to strengthen immune function of human body for elimination of any abnormal cells such as virus-infected or malignant cells from the body.
This report aims to provide a comprehensive presentation of the global market for Immuno-Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-Cell Therapy. This report contains market size and forecasts of Immuno-Cell Therapy in global, including the following market information:
Global Immuno-Cell Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Immuno-Cell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Passive Immune (NK, LAK etc) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Immuno-Cell Therapy include MEDINET Co, Erytech, Seta Clinic Group, Takeda, SBI Holdings, Oxford BioTherapeutics, Fate Therapeutics, Gilead Sciences and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Immuno-Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immuno-Cell Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Immuno-Cell Therapy Market Segment Percentages, by Type, 2022 (%)
Passive Immune (NK, LAK etc)
Active Immune
Global Immuno-Cell Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Immuno-Cell Therapy Market Segment Percentages, by Application, 2022 (%)
Oncology
Cardiovascular Disease (CVD)
Orthopedic
Wound Healing
Others
Global Immuno-Cell Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Immuno-Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immuno-Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Immuno-Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
MEDINET Co
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immuno-Cell Therapy, market overview.
Chapter 2: Global Immuno-Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Immuno-Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immuno-Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
